Abstract:The aim of this study was to compare clinical characteristics, electroneurography (ENoG) results, and functional outcomes of patients with Bell's palsy (BP) and Ramsay Hunt syndrome (RHS).Around 57 patients with BP and 23 patients with RHS were enrolled in this study from January 2010 and September 2015. Both clinical characteristics and ENoG results were recorded at hospital admission. The evaluations of functional outcomes were conducted with House–Brackmann (H-B) grading system at 6-month follow-up.There we… Show more
“…However, the results of this study differ from previous studies undertaken in Korea [18][19][20][21] that a history of diabetes mellitus and hypertension is not significant in the prognosis of facial palsy. However, the results of this study showing that hypertension, diabetes mellitus are statistically significant with the prognosis of facial palsy are consistent with studies from other countries 16,17) . Further research is needed on this matter.…”
“…However, the results of this study differ from previous studies undertaken in Korea [18][19][20][21] that a history of diabetes mellitus and hypertension is not significant in the prognosis of facial palsy. However, the results of this study showing that hypertension, diabetes mellitus are statistically significant with the prognosis of facial palsy are consistent with studies from other countries 16,17) . Further research is needed on this matter.…”
“…The incidence of AFP in the literature is found to be 30/100,000, and the most common causes are BP and RHS. [1,3] The etiopathogenesis of BP is still unclear. Infection, genetic factors, microvascular circulatory impairment, immunological factors, and inflammation have been blamed.…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of AFP is found to be 30/100,000 in the literature. [1] It can be caused by many diseases, such as cancer, trauma, Bell's palsy (BP), Ramsay Hunt syndrome (RHS), and iatrogenic injury. [1,2] The most common causes among these are BP and RHS.…”
Section: Introductionmentioning
confidence: 99%
“…[1] It can be caused by many diseases, such as cancer, trauma, Bell's palsy (BP), Ramsay Hunt syndrome (RHS), and iatrogenic injury. [1,2] The most common causes among these are BP and RHS. [1,3] The incidence of BP is 15-30/100,000 in the literature.…”
Section: Introductionmentioning
confidence: 99%
“…[1,2] The most common causes among these are BP and RHS. [1,3] The incidence of BP is 15-30/100,000 in the literature. [4] The etiology of the disease is not clear, but vascular causes, autoimmune diseases, and inflammation of the nerve sheath are indicated in the pathogenesis.…”
Objective: Acute facial paralysis (AFP) is one of the most common complaints of patients who were admitted to the otolaryngology emergency clinics. It is important to diagnose and provide accurate treatment for AFP because misdiagnosis or late treatment may result with permanent unwanted outcomes. The aim of the present study was to investigate the usefulness of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients diagnosed with Bell's palsy (BP) with or without diabetes for the differential diagnosis and alternative treatment modalities of patients with BP. Methods: Patients who were admitted to the Kartal Dr. Lutfi Kırdar Training and Research Hospital emergency department with a complaint of acute peripheral facial paralysis diagnosed with BP between January 2013 and February 2017 were evaluated retrospectively. Eighteen patients with BP and 17 patients with BP and type 2 diabetes mellitus (T2DM) were included in the study. Results: Thirty-five patients diagnosed with facial paralysis were evaluated. It was statistically significant that the number of diabetic females with BP was higher than that of males (p=0.035). Seventeen patients with BP and 18 patients with T2DM and BP were evaluated, and there was no statistical significance between both groups' NLR and PLR values. Conclusion: There was no statistically significant difference between NLR and PLR between patients with BP with T2DM and non-DM.
Objectives
There is a lack of data on patients’ and diagnostic factors for prognostication of complete recovery in patients with non-idiopathic peripheral facial palsy (FP).
Methods
Cohort register-based study of 264 patients with non-idiopathic peripheral FP and uniform diagnostics and standardized treatment in a university hospital from 2007 to 2017 (47% female, median age: 57 years). Clinical data, facial grading, electrodiagnostics, motor function tests, non-motor function tests, and onset of prednisolone therapy were assessed for their impact on the probability of complete recovery using univariable and multivariable statistics.
Results
The most frequent reason for a non-idiopathic peripheral FP was a reactivation of Varicella Zoster Virus (VZV; 36.4%). Traumatic origin had a higher proportion of complete FP (52.9%). Furthermore, in traumatic FP, the mean interval between onset and start of prednisolone therapy was longer than in other cases (5.6 ± 6.2 days). Patients with reactivation of VZV, Lyme disease or otogenic FP had a significant higher recovery rate (p = 0.002, p < 0.0001, p = 0.018, respectively), whereas patients with post-surgery FP and other reasons had a significant lower recovery rate (p < 0.0001). After multivariate analyses voluntary activity in first EMG, Lyme disease and post-surgery cause were identified as independent diagnostic and prognostic factors on the probability of complete recovery (all p < 0.05).
Conclusion
Infectious causes for non-idiopathic FP like VZV reactivation and Lyme disease had best probability for complete recovery. Post-surgery FP had a worse prognosis.
Level of evidence
2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.